Medicine
Forane 1 mL/mL inhalant
Forane 1 mL/mL inhalant is a prescription medicine containing Isoflurane for inhalation use, marketed by Baxter Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature 15°C - 30°C (59°F - 86°F). Isoflurane contains no…
Key facts
- Active ingredient (INN)
- Isoflurane
- Brand
- Forane
- Strength
- 1 mL/mL
- Dosage form
- Inhalant
- Route
- Inhalation
- Packs
- 6 bottles
- Marketing authorisation holder
- Baxter Healthcare
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Store at room temperature 15°C - 30°C (59°F - 86°F). Isoflurane contains no additives and has been demonstrated to be stable at room temperature for periods in excess of five years.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01AB06 Isoflurane
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 December 1979
- Identifiers
- RxCUI 542347, 542358DailyMed set ID 3d30eb8d-a62e-475f-926b-78ba63bee9c8NDC 10019-360Application NDA017624
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 bottle, glass in 1 package / 100 mL in 1 bottle, glass | 10019-360-40 | Baxter Healthcare | 18 December 1979 |
| 6 bottle, glass in 1 package / 250 mL in 1 bottle, glass | 10019-360-60 | Baxter Healthcare | 18 December 1979 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 December 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Isoflurane
Clinical summary
Isoflurane is a general anesthetic indicated for induction and maintenance of general anesthesia. It is available as inhalation solution and inhalant. MedsAcross supplies Isoflurane for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IsofluraneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FORANE prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Forane 1 mL/mL inhalant for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.